Stock Market Today, Dec. 19: Nike Shares Slide After Weak China Sales and Margin Pressure

Nike shares plunged 10.5% to $58.70 on heavy 95.4M volume after quarterly results showed revenue up just 1% while EPS fell 32%, gross margins contracted ~300 basis points and China sales declined 17%, raising concerns about demand and margins. Management flagged mixed trends — North American wholesale revenue rose 20% as retailer relationships repair — but the stock still trades at about 29x free cash flow, leaving investors focused on guidance and a return to growth before re-rating the shares.

Analysis

Market structure: Nike’s 10.5% one-day drop on 95.4M shares (≈+400% vs 3‑month avg), -300bp gross margin and China sales -17% reallocates short-term demand toward North American wholesale partners (Foot Locker, DKS) while penalizing China-exposed supply chains and European peers (Adidas/Puma). Pricing power is under stress — 300bp margin compression implies either higher costs, heavier promotions, or unfavorable FX; if promotions intensify, unit economics and sector ASPs will be pressured for multiple quarters.

Risk assessment: Near-term (days-weeks) expect elevated volatility and potential further downgrades if monthly China retail prints below -5% or inventory days increase >10% QoQ; tail risks include renewed China lockdowns, tariff spikes lifting COGS >200–300bp, or an unexpected inventory write-down that flips FCF negative. Hidden dependency: wholesale NA +20% recovery is conditional on retailers destocking completed by Q2–Q3; if retailers instead over-order, the rebound will be transient and margins will re-compress.

Trade implications: Tactical downside hedge now — buy 3‑month 55 puts or a 55/50 put spread (size to 1–2% of portfolio) to protect against further downside through next earnings; medium-term opportunistic long via a 6–12 month 60/80 call spread (debit) if NKE stabilizes < $60 and China sequentially improves over two months. Rotate 2–4% from discretionary into staples/consumer staples and select industrials; implement pair trade long NKE vs short XLY (equal $ notional) to express idiosyncratic recovery while hedging macro consumer risk.

Contrarian angles: Consensus prices in structural China decline; it’s plausible this is overdone if wholesale NA momentum continues and management uses pricing/promotions to clear inventories — FCF valuation (29x) will compress quickly then re-expand as margins normalize, creating a 6–12 month asymmetric upside. Mispricing trigger: if Nike reports China sales decline moderating to < -5% next quarter and gross margin improvement of ≥150bp, expect a 20–35% mean reversion rally from oversold levels.

Key Decisions for Investors

• Establish a tactical hedge: buy 3‑month NKE 55 puts (or 55/50 put spread) sized to 1–2% of portfolio to protect through next earnings and China retail prints.
• If NKE trades below $50, accumulate a strategic long position sized 2–3% of portfolio via buy-and-hold with 2‑month covered calls sold at $65 (generate yield while holding), stop-loss at $44.
• Enter a 6–12 month bullish call spread (buy 60 / sell 80) sized to 0.5–1% of portfolio if NKE stabilizes < $60 and management signals sequential margin improvement; target 30–80% return if recovery accelerates.
• Implement a relative value pair: long NKE vs short XLY (equal dollar exposure) sized to 1–2% net exposure to isolate idiosyncratic recovery while hedging sector risk over next 3–6 months.
• Reduce gross exposure to consumer discretionary by 2–4% and redeploy into staples/defensive names (e.g., KHC/PG) until two positive signals arrive: China sales QoQ decline <5% and gross margin improvement ≥150bp.